We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$487M
AUM Growth
+$60.8M
Cap. Flow
+$38.3M
Cap. Flow %
7.87%
Top 10 Hldgs %
34.77%
Holding
122
New
17
Increased
29
Reduced
59
Closed
5

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$7.16M
2
ABT icon
Abbott
ABT
+$4.51M
3
DUK icon
Duke Energy
DUK
+$3.52M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$3.16M
5
SCG
Scana
SCG
+$2.45M

Top Sells

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$2.45M
2
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$2.24M
3
JNJ icon
Johnson & Johnson
JNJ
+$1.46M
4
GSK icon
GSK
GSK
+$497K
5
AMAT icon
Applied Materials
AMAT
+$423K

Sector Composition

Rank Sector Weight
1 Healthcare 27.69%
2 Industrials 18.44%
3 Technology 17.48%
4 Utilities 8.95%
5 Energy 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$599B
$31.1M 6.38%
256,309
-12,856
-5% -$1.46M
GLW icon
2
Corning
GLW
$132B
$19.4M 3.99%
948,099
+18,754
+2% +$376K
XOM icon
3
ExxonMobil
XOM
$615B
$18.7M 3.84%
199,697
-1,085
-0.5% -$95.9K
EMR icon
4
Emerson Electric
EMR
$76.5B
$17.8M 3.66%
341,288
+42,600
+14% +$2.26M
PFE icon
5
Pfizer
PFE
$141B
$17.3M 3.54%
516,432
-5,533
-1% -$177K
SLB icon
6
SLB Ltd
SLB
$69.4B
$14.6M 3%
184,881
+6,375
+4% +$489K
GVA icon
7
Granite Construction
GVA
$5.34B
$14.2M 2.91%
311,027
-3,450
-1% -$152K
MRK icon
8
Merck
MRK
$307B
$12.8M 2.64%
233,439
-3,065
-1% -$163K
INTC icon
9
Intel
INTC
$488B
$12M 2.46%
364,825
+12,000
+3% +$376K
LNN icon
10
Lindsay Corp
LNN
$1.15B
$11.5M 2.35%
168,757
+12,375
+8% +$880K
BMY icon
11
Bristol-Myers Squibb
BMY
$123B
$10.5M 2.16%
142,853
-1,481
-1% -$105K
BCE icon
12
BCE
BCE
$20.2B
$9.61M 1.97%
203,166
-2,762
-1% -$128K
WMT icon
13
Walmart Inc
WMT
$893B
$9.54M 1.96%
392,100
-6,000
-2% -$139K
GXP
14
DELISTED
Great Plains Energy Incorporated
GXP
$9.04M 1.86%
297,300
-2,220
-0.7% -$68.1K
AMAT icon
15
Applied Materials
AMAT
$417B
$9.02M 1.85%
376,425
-19,185
-5% -$423K
DUK icon
16
Duke Energy
DUK
$98.1B
$8.43M 1.73%
98,288
+44,010
+81% +$3.52M
GSK icon
17
GSK
GSK
$100B
$7.91M 1.63%
146,074
-9,426
-6% -$497K
IBM icon
18
IBM
IBM
$200B
$7.75M 1.59%
53,413
-2,903
-5% -$416K
HON icon
19
Honeywell
HON
$71.7B
$7.33M 1.5%
70,083
-1,475
-2% -$152K
TEL icon
20
TE Connectivity
TEL
$59.3B
$7.3M 1.5%
127,900
+118,925
+1,325% +$7.16M
AZTA icon
21
Azenta
AZTA
$1.21B
$7.24M 1.49%
644,840
-1,175
-0.2% -$12.3K
GM icon
22
General Motors
GM
$68.3B
$6.82M 1.4%
241,100
+41,138
+21% +$1.25M
OTTR icon
23
Otter Tail
OTTR
$3.83B
$6.76M 1.39%
201,814
-4,100
-2% -$123K
STJ
24
DELISTED
St Jude Medical
STJ
$6.67M 1.37%
85,534
+12,675
+17% +$904K
TT icon
25
Trane Technologies
TT
$103B
$6.43M 1.32%
101,004
-700
-0.7% -$45K
1
2 3 4 5

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
SF
Symphony Financial Houston, Texas $755M AUM 25.99% 1-Year Est. Return
MSWM
McGlone Suttner Wealth Management Appleton, Wisconsin $755M AUM 16.66% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM

John G. Ullman & Associates's Q2 2016 Portfolio in Review

As of Q2 2016, John G. Ullman & Associates held 122 positions worth $487M, up 14% from $426M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

John G. Ullman & Associates deployed $38.3M of net new capital in Q2 2016, opening 17 new positions and adding to 29 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 57,720 shares worth $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 27% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.46M trimmed.

  • John G. Ullman & Associates's largest Q2 2016 buy was State Street SPDR S&P Biotech ETF: 57,720 shares worth $3.12M.
  • John G. Ullman & Associates added most to TE Connectivity in Q2 2016, an estimated $7.16M increase.
  • John G. Ullman & Associates's biggest Q2 2016 reduction was Johnson & Johnson, cutting an estimated $1.46M.
  • John G. Ullman & Associates fully exited Booking.com in Q2 2016, selling an estimated $2.45M.
  • John G. Ullman & Associates's ten largest holdings make up 35% of its $487M portfolio in Q2 2016.
  • John G. Ullman & Associates opened 17 new positions and closed 5 in Q2 2016.
  • John G. Ullman & Associates's portfolio value rose 14% quarter-over-quarter to $487M.

Based on John G. Ullman & Associates's 13F filing for Q2 2016, filed 22 Jul 2016.